TEL : 028-85121781
Set Homepage | Add Favorite     中文 | English
Home > Dynamic Center > Enterprise Dynamic >
Enterprise Dynamic
Report on Protocol Seminar on the Treatment of Advanced Lung Cancer with Chlorogenic Acid for Injection

On 1 April 2018, a conference was held at Guangxi Building in Beijing to discuss the protocol of the single arm, open-label, multicenter, phase Ib/IIa clinical study for chlorogenic acid for injection in treating advanced lung cancer.

Prev:Phase I clinical trial of chlorogenic acid for injection showed efficacy beyond the investigator's estimation
Next:Jiuzhang Biotech Protocol Seminar on Chlorogenic Acid for Injection successfully completed in May 2018